Albuterol Sulfate Aerosol, Metered
Product Images NDC 66993-019

15 FDA label images from Prasco Laboratories · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Albuterol Sulfate (NDC 66993-019). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Prasco Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Albuterol Sulfate Chemical Structure (Albuterolhfa Spl Graphic 01)

Albuterol Sulfate Chemical Structure (Albuterolhfa Spl Graphic 01)
Chemical structure of albuterol sulfate showing the molecular arrangement, including hydroxyl groups and the sulfate salt form, as indicated by the presence of H2SO4.*
FDA Label Image

Fev1 As Percent Change From Predose In A Large, 12-week Clinical Trial, Day 1 (Albuterolhfa Spl Graphic 02)

Fev1 As Percent Change From Predose In A Large, 12-week Clinical Trial, Day 1 (Albuterolhfa Spl Graphic 02)
A line graph depicting mean percent change from baseline over time (hours) for three groups: CFC 11/12-propelled albuterol (2 inhalations, 4 times daily), albuterol sulfate HFA (2 inhalations, 4 times daily), and HFA-134a placebo inhaler (2 inhalations, 4 times daily). The y-axis shows mean percent change from baseline, and the x-axis represents time in hours from 0 to 6. The graph compares the bronchodilator effect over 6 hours for each inhaler group.*
FDA Label Image

Fev1 As Percent Change From Predose In A Large, 12-week Clinical Trial, Week 12 (Albuterolhfa Spl Graphic 03)

Fev1 As Percent Change From Predose In A Large, 12-week Clinical Trial, Week 12 (Albuterolhfa Spl Graphic 03)
A line graph showing the mean percentage change from baseline over time (hours) for three treatments: CFC 11/12-propelled albuterol, albuterol sulfate HFA, and an HFA-134a placebo inhaler. The graph tracks 2 inhalations taken 4 times daily, with data points compared across 6 hours, illustrating treatment effects on the measured outcome.*
FDA Label Image

Figure A (Albuterolhfa Spl Graphic 04)

Figure A (Albuterolhfa Spl Graphic 04)
An illustration of an Albuterol Sulfate HFA metered aerosol inhaler showing its components: a metal canister, blue plastic actuator, blue mouthpiece, a counter on the base, and a detachable blue cap covering the mouthpiece.*
FDA Label Image

Figure B (Albuterolhfa Spl Graphic 05)

Figure B (Albuterolhfa Spl Graphic 05)
An instructional diagram depicting a person removing the protective cap from the mouthpiece of an aerosol metered inhaler, shown being held in one hand while the other hand pulls the cap off the device.*
FDA Label Image

Figure C (Albuterolhfa Spl Graphic 06)

Figure C (Albuterolhfa Spl Graphic 06)
Instructional illustration showing a person using an Albuterol Sulfate HFA metered dose inhaler. The person aims the inhaler mouthpiece forward and presses down on the canister to release a spray dose for respiratory inhalation.*
FDA Label Image

Figure D (Albuterolhfa Spl Graphic 07)

Figure D (Albuterolhfa Spl Graphic 07)
An illustration showing a hand holding an inhaler device with a counter display reading '200'. The image likely demonstrates proper grip or use of a metered-dose inhaler for respiratory medication.*
FDA Label Image

Figure E (Albuterolhfa Spl Graphic 08)

Figure E (Albuterolhfa Spl Graphic 08)
An instructional illustration showing how to hold an Albuterol Sulfate HFA metered dose inhaler with the mouthpiece down. Labels indicate the blue mouthpiece and the separate blue cap. A hand is depicted pressing the inhaler canister.*
FDA Label Image

Figure F (Albuterolhfa Spl Graphic 09)

Figure F (Albuterolhfa Spl Graphic 09)
An instructional illustration showing a side profile of a person's face exhaling. Text instructs to "Breathe out as much air as you can" with an arrow indicating the direction of airflow from the mouth.*
FDA Label Image

Figure G (Albuterolhfa Spl Graphic 10)

Figure G (Albuterolhfa Spl Graphic 10)
An instructional illustration demonstrating the use of a metered-dose inhaler. It shows a person holding the inhaler close to their mouth with the instruction 'Push down and breathe in,' indicating how to properly inhale the medication.*
FDA Label Image

Figure H (Albuterolhfa Spl Graphic 11)

Figure H (Albuterolhfa Spl Graphic 11)
Instructional diagram showing correct and incorrect use of an inhaler spray. The top image illustrates an unblocked spray emitting medication properly. The bottom image shows a blocked spray with no proper release, indicating improper use of the inhaler device.*
FDA Label Image

Figure I (Albuterolhfa Spl Graphic 12)

Figure I (Albuterolhfa Spl Graphic 12)
An instructional illustration showing a hand holding an albuterol sulfate inhaler under running water from a faucet, with water visibly splashing. This image likely demonstrates how to clean the inhaler device properly.*
FDA Label Image

Figure J (Albuterolhfa Spl Graphic 13)

Figure J (Albuterolhfa Spl Graphic 13)
An instructional illustration showing a hand holding an albuterol sulfate inhaler canister with water flowing over its mouthpiece, demonstrating cleaning of the inhaler mouthpiece under running water.*
FDA Label Image

Figure K (Albuterolhfa Spl Graphic 14)

Figure K (Albuterolhfa Spl Graphic 14)
An instructional illustration depicting the components of an Albuterol Sulfate HFA aerosol inhaler, including the mouthpiece cover, mouthpiece, and the canister. The image indicates a nighttime setting with a crescent moon symbol, possibly related to dosing or usage timing instructions.*
FDA Label Image

Albuterol Sulfate Hfa 200 Dose Label (Albuterolhfa Spl Graphic 15)

Albuterol Sulfate Hfa 200 Dose Label (Albuterolhfa Spl Graphic 15)
Label for Albuterol Sulfate HFA inhalation aerosol, 90 mcg per actuation, with 200 metered inhalations. The label includes usage instructions, storage conditions, weight (18 g), manufacturer (Prasco Laboratories, Mason, OH), and warnings such as not to exceed the prescribed dose and to shake well before use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.